Zoetis launches osteoarthritis drugs LIBRELA® and SOLENSIA® in Europe

Zoetis has announced the launch of LIBRELA® (bedinvetmab) and SOLENSIA® (frunevetmab) in Europe, which are the first products in a … Continue reading Zoetis launches osteoarthritis drugs LIBRELA® and SOLENSIA® in Europe